BPG is committed to discovery and dissemination of knowledge
Articles in Press
2/9/2026 8:41:07 AM | Browse: 2 | Download: 0
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 118319
Country China
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Converting cold to hot: Strategies to sensitize microsatellite-stable colorectal cancer to immunotherapy
Manuscript Source Invited Manuscript
All Author List Feng Chi, Chi-Bo Liu, Jian Li, Xian-Wu Xia, Qian-Jin Hua and Wei Wang
Funding Agency and Grant Number
Corresponding Author Wei Wang, MD, Research Dean, Researcher, Department of Interventional Oncology, Municipal Hospital Affiliated to Taizhou University, No. 581 Shifu Avenue East, Jiaojiang District, Taizhou 318000, Zhejiang Province, China. wangw@tzc.edu.cn
Key Words Adoptive cell therapy; Anti-angiogenic therapy; Biomarkers; Immune checkpoint inhibitors; Immune exclusion; Microsatellite-stable colorectal cancer; Tumor microenvironment; Vaccine
Core Tip Most colorectal cancers are microsatellite-stable (MSS)/proficient mismatch repair and remain largely refractory to single-agent immune checkpoint inhibitors. This review dissects major resistance determinants low neoantigen burden, impaired antigen presentation, immune exclusion by cancer-associated fibroblast-rich stroma and abnormal vasculature, and myeloid-dominant suppression, particularly in liver metastases. We synthesize current evidence for rational “cold-to-hot” strategies, spanning chemo/radiotherapy priming, anti-angiogenic and anti-epidermal growth factor receptor regimens, mitogen-activated protein kinase/Wnt/transforming growth factor-β/CXCR4-signal transducer and activator of transcription 3 pathway targeting, and emerging vaccines, oncolytic viruses, cell therapies, and microbiome modulation. A biomarker-guided roadmap is proposed to personalize combination immunotherapy in MSS colorectal cancer.
Citation Chi F, Liu CB, Li J, Xia XW, Hua QJ, Wang W. Converting cold to hot: Strategies to sensitize microsatellite-stable colorectal cancer to immunotherapy. World J Gastrointest Oncol 2026; In press
Received
2025-12-30 05:59
Peer-Review Started
2025-12-30 05:59
First Decision by Editorial Office Director
2026-01-06 07:10
Return for Revision
2026-01-06 07:10
Revised
2026-01-12 14:12
Publication Fee Transferred
Second Decision by Editor
2026-02-09 02:47
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-02-09 08:41
Articles in Press
2026-02-09 08:41
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com